HER-2/NEU IN TISSUE AND SERUM AT TIME OF PRIMARY DIAGNOSIS OF BREAST CANCER

被引：0
|
作者：
Dresse, M. [1 ]
Mayr, D. [2 ]
Heinemann, V. [3 ]
Kahlert, S. [4 ]
Bauerfeind, I. [4 ]
Nagel, D. [1 ]
Seidel, D. [1 ]
Stieber, P. [1 ]
机构：
[1] Univ Hosp, Inst Clin Chem, Munich, Germany
[2] Univ Hosp, Inst Pathol, Munich, Germany
[3] Univ Hosp, Dept Med 3, Munich, Germany
[4] Univ Hosp, Dept Gynecol, Munich, Germany
来源：
ANTICANCER RESEARCH | 2008年 / 28卷 / 6B期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
33
引用
收藏
页码：4027 / 4027
页数：1
相关论文
共 50 条
  • [41] Serum EGFr and HER-2/neu predicts poor survival in metastatic breast cancer
    Hamer, P. J.
    Jarosz, D. E.
    Leitzel, K.
    Ali, S. M.
    Demers, L.
    Evans, D. B.
    Chaudri-Ross, H. A.
    Lipton, A.
    Camey, W. P.
    CLINICAL CHEMISTRY, 2006, 52 (06) : A168 - A168
  • [42] Prognostic value of serum level of HER-2 extracellular domain (ECD) at diagnosis of HER-2 overexpressed primary breast cancer (BC)
    Thureau, S.
    Clatot, F.
    Pille, J.
    Laberge-Le-Couteulx, S.
    Rigal, O.
    Veyret, C.
    Basuyau, J.
    Blot, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [43] HER-2/neu overexpression and in vitro chemosensitivity to CMF and FEC in primary breast cancer
    Konecny, G
    Fritz, M
    Untch, M
    Lebeau, A
    Felber, M
    Lude, S
    Beryt, M
    Hepp, H
    Slamon, D
    Pegram, M
    BREAST CANCER RESEARCH AND TREATMENT, 2001, 69 (01) : 53 - 63
  • [44] HER-2/neu Breast Cancer Diagnosis Procedure, Based on Histopathology Image Analysis
    Tabakov, Martin
    Tabakov, Marta
    Kwasnicka, Halina
    Kozak, Pawel
    Pula, Bartosz
    PROCEEDINGS IWBBIO 2014: INTERNATIONAL WORK-CONFERENCE ON BIOINFORMATICS AND BIOMEDICAL ENGINEERING, VOLS 1 AND 2, 2014, : 135 - 146
  • [45] HER-2/neu Expression in Primary Breast Cancer With Sentinel Lymph Node Metastasis
    S. David Nathanson
    Robert Slater
    Deborah DeBruyn
    Alissa Kapke
    Michael Linden
    Annals of Surgical Oncology, 2006, 13 : 205 - 213
  • [46] Her-2/neu expression in primary breast cancer and its lymph node metastases
    Cardoso F.
    Breast Cancer Research, 3 (1)
  • [47] HER-2/neu overexpression and in vitro chemosensitivity to CMF and FEC in primary breast cancer
    Gottfried Konecny
    Manuel Fritz
    Michael Untch
    Annette Lebeau
    Margrit Felber
    Sandra Lude
    Malgorzata Beryt
    Hermann Hepp
    Dennis Slamon
    Mark Pegram
    Breast Cancer Research and Treatment, 2001, 69 : 53 - 63
  • [48] HER-2/neu gene amplification and protein expression in primary male breast cancer
    Rudlowski, C
    Friedrichs, N
    Faridi, A
    Füzesi, L
    Moll, R
    Bastert, G
    Rath, W
    Büttner, R
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 84 (03) : 215 - 223
  • [49] An early decrease in serum HER-2/neu levels after initiation of primary chemotherapy for HER-2 positive breast cancer indicates response to treatment.
    Mazouni, C.
    Hall, A.
    Anderson, K.
    Peintinger, F.
    Frische, H.
    Andre, F.
    Yekell, S.
    Arun, B.
    Buzdar, A. U.
    Esteva, F.
    Pusztai, L.
    Cristofanilli, M.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S51 - S51
  • [50] Her-2/neu Gene Amplification and Protein Expression in Primary Male Breast Cancer
    Christian Rudlowski
    Nicolaus Friedrichs
    Andree Faridi
    Lazlo Füzesi
    Roland Moll
    Gunther Bastert
    Werner Rath
    Reinhard Büttner
    Breast Cancer Research and Treatment, 2004, 84 : 215 - 223
12345